home All News open_in_new Full Article

Belite Bio, Inc to Present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference May 15th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that CSO, Dr. […]


today 10 h. ago attach_file Culture

attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Society
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture


ID: 2149728362
Add Watch Country

arrow_drop_down